Scilex Holding (SCLX) Share-based Compensation (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Share-based Compensation of $3.6 million for Q1 2026, up 9.51% year-over-year from $3.3 million in Q1 2025, and up 148.72% on a QoQ basis from -$7.4 million in Q4 2025.

Scilex Holding (SCLX) Share-based Compensation (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Share-based Compensation for 5 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Share-based Compensation rose 9.51% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $2.7 million (down 82.42% YoY), while the FY2025 annual figure was $2.4 million, down 84.7% from the prior year.
  • Share-based Compensation came in at $3.6 million for Q1 2026 at Scilex Holding, up from -$7.4 million in the prior quarter.
  • The five-year high for Share-based Compensation was $4.8 million in Q4 2024, with the low at -$7.4 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $2.4 million, with a median of $3.5 million recorded in 2023.
  • Across the five-year window, Share-based Compensation surged 201.92% in 2023 and plunged 255.03% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $1.3 million in 2022, then soared by 201.92% to $3.8 million in 2023, then gained by 27.02% to $4.8 million in 2024, then slumped by 255.03% to -$7.4 million in 2025, then surged by 148.72% to $3.6 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $3.6 million, -$7.4 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 161.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 300.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 444.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 185.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 218.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 272.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 3.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.63 Mn
Mar 31, 2026 3.63 Mn
Dec 31, 2025 -7.45 Mn
Dec 31, 2025 -7.45 Mn
Sep 30, 2025 3.26 Mn
Sep 30, 2025 3.26 Mn
Jun 30, 2025 3.28 Mn
Jun 30, 2025 3.28 Mn
Mar 31, 2025 3.31 Mn
Mar 31, 2025 3.31 Mn
Dec 31, 2024 4.81 Mn
Dec 31, 2024 4.81 Mn
Sep 30, 2024 3.71 Mn
Sep 30, 2024 3.71 Mn
Jun 30, 2024 3.61 Mn
Jun 30, 2024 3.61 Mn
Mar 31, 2024 3.56 Mn
Mar 31, 2024 3.56 Mn
Dec 31, 2023 3.78 Mn
Dec 31, 2023 3.78 Mn